Key Insights

Highlights

Success Rate

67% trial completion

Treatment Research

3 treatments under study, led by Pa100 Ast

Research Leaders

13 sponsors active, led by University of Bristol

Related Conditions

Often studied with 14 related conditions

Clinical Risk Assessment

Based on trial outcomes

High Risk

Score: 72/100

Termination Rate

20.0%

1 terminated out of 5 trials

Success Rate

66.7%

-19.9% vs benchmark

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 2 completed with results

Key Signals

67% success

Data Visualizations

Phase Distribution

3Total
Not Applicable (3)

Trial Status

Completed2
Unknown1
Not Yet Recruiting1
Terminated1

Trial Success Rate

66.7%

Benchmark: 86.6%

Based on 2 completed trials

Clinical Trials (5)

Showing 5 of 5 trials
NCT07711756Not Yet Recruiting

Comparative Study of Adherence to Antibiotic Therapy Among Pediatric Patients: Hospital Emergency Department vs. Primary Care Center

NCT05510128Not ApplicableTerminatedPrimary

Evaluation of the Effectiveness of a Protocol for the Management of Female Functional Urinary Signs

NCT07189429Not ApplicableCompleted

Clinical Impact Analysis of PA-100 AST in a Spanish GP Setting

NCT05667207Not ApplicableCompletedPrimary

Dipsticks and Microscopy to Reduce Antibiotic Use in Women's Urinary Tract Infections: a Pilot Trial (MicUTI)

NCT06267040UnknownPrimary

Linguistic and Clinical Validation of the Arabic Version of Acute Cystitis Symptom Score (ACCS)

Showing all 5 trials

Research Network

Common Treatments

  • Pa100 Ast1
  • Pharmacist Management1
  • Pointofcare Microscopy And Dipstick Guided Management1

Active Sponsors

  • University of Bristol1
  • Sysmex Europe GmbH1
  • University Hospital, Angers1
  • Al-Kindy College of Medicine1
  • LMU Klinikum1

Top Investigators

Related Conditions

  • Otitis Media Acute1
  • Sinusitis Bacterial1
  • Urinary Tract Infection Bacterial1
  • Pneumonia Atypical1
  • Amr1

Activity Timeline